Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

PARTICIPANT INFORMATION SHEET FOR THOSE PARTICIPATING IN THE LEARN WITH NURSES PILL SWALLOWING WEBINAR Research Ethics Committee Reference Number: 22/PBS/006 Title of Study: Learn With Nurses Webinar on Pill Swallowing You are being invited to take part in a research study. You do not have to take part if you do not want to. Please read this information, which will help you decide. 1. What is the purpose of the study? This study will teach healthcare professionals about a validated screening tool to identify pill aversion/ pill swallowing issues in adults. We will teach you a validated training technique to improve pill swallowing in patients of all ages called KidzMed.This study hopes to answer the following questions: - What are your experiences of pill swallowing? - What are your views on the training provided - If you have or will put your learning into practice 2. Why have I been invited to participate? You have been invited because you are a healthcare professional who is a potential and or registered delegate at the Learn With Nurses pill swallowing webinar and are thus eligible to participate. Exclusion criteria – Those who do not wish to participate or who do not sign up to the pill swallowing webinar will be excluded. 3. Do I have to take part? No. You can ask questions about the research before deciding whether to take part. If you do not want to take part that is OK. You can still join the pill swallowing webinar if you do not want to take part. You will be asked to complete anonymous electronic questionnaires. Submitting the questionnaire impliesyourconsenttoparticipateinthisstudy. Youcanstopbeingpartofthestudyatanytime,without giving a reason by pressing the ‘Exit’ button/ closing the browser 4. What will happen to me if I take part? You can either sign up directly to the webinar or sign up to the webinar via participation in this study. Participation in the study is not essential in order to participate in the webinar. You will show intention to consent by clicking on the link to a short (less than 5 minutes) electronic pre- webinar anonymous quiz. This will include a compulsory opening statement which you must electronically tick YES to indicating your agreement to participate. You do not have to answer any questions that you do not wish to and can withdraw at any point up until the point of submission by closing the browser. Once the electronic quizzes are submitted it will not be possible to withdraw from the study as no personally identifiable information will be collected. This applies for all quizzes the pre-quiz, post-webinar quiz and follow-up quizzes referred to below. Participant information sheet Version No. 1 Date: 19/11/22 Thepre-quizwillaskyouto reflectonyourownexperiencesofpillswallowingandyourown practice- have you ever asked a patient about pill swallowing difficulties? had any training on this topic? or used any methods to help patients take their pills more easily? The webinar (approximately 45 mins) will run on the advertised date and time and you will listen to an introductory presentation around pill swallowing with a live demonstration of an interventional pill swallowing training technique. At the end of the session you will be asked to complete a short electronic post-webinar quiz (less than 5 minutes to complete) providing your views on the webinar. Afollow-upelectronicquiz(lessthan5minutestocomplete)willbecirculated8weeksafterthewebinar to all delegates asking them if they have put their learning into practice and to provide some further details on this. 5. Are there any potential risks in taking part? Participating in the research is not anticipated to cause you any disadvantages or discomfort. The potential physical and/or psychological harm ordistress will be the same as any experienced in everyday life 7. Are there any benefits in taking part? The benefits of taking part are that you will learn something new through attending the webinar and will be able should you wish to apply your learning to your everyday practice. The potential or hoped for benefits of the study for the wider society are that by raising awareness of pill aversion among healthcare professionals more of us will hold open discussions with our patients on this topic and be able to provide advice to overcome these if we identify those struggling to swallow their pills. 8. Payments, reimbursements of expenses or any other benefit or incentive for taking part There will be no payment or any benefit or incentive for taking part in this study. Unfortunately, we cannot reimburse any expenses you may incurred. 9. What will happen to information/data provided? The information you provide as part of the study is the study data. Any study data from which you can be identified (e.g. from identifiers such as your name, date of birth, audio recording etc.), is known as personaldata. Yourparticipation in this study will not involve the collection/use ofpersonal data by the investigator. All study data is anonymous so you cannot be directly identified from the data. Study data will be kept forthree years after the study has finished as perLJMU policy. We keep the data so we can check the results. We will write our reports in a way that no-one can work out that you took part in the study. We would like your permission to use direct quotations [but without identifying you] in any research outputs. 10. Who is organising the study? This study is organised by Liverpool John Moores University. 11. Whom do I contact if I have a concern about the study or I wish to complain? If you have a concern about any aspect of this study, please contact Dr Alice McCloskey and we will do ourbesttoansweryourquery. You shouldexpectareply within10workingdays. Ifyouremainunhappy or wish to make a formal complaint, please contact the Chair of the Research Ethics Committee at LiverpoolJohnMooresUniversitywhowillseektoresolve thematterassoonaspossible:Chair,Liverpool John Moores University Research Ethics Committee; Email: FullReviewUREC@ljmu.ac.uk; Tel: 0151 231 2121; Research Innovation Services, Liverpool John Moores University, Exchange Station, Liverpool L2 2QP Participant information sheet Version No. 1 Date: 19/11/2212. Contact details Principal Investigator: Dr Alice Patricia McCloskey LJMU Email address: a.p.mccloskey@ljmu.ac.uk LJMU School/faculty: School of Pharmacy and biomolecular science LJMU Central telephone number: 0151 231 2121 Please note that you may only participate in this survey if you are 18 years of age or over. ☐ I certify that I am 18 years of age or over If you have read the information above and agree to participate with the understanding that the data (including any personal data) you submit will be processed accordingly, please tick the box below to start. ☐ Yes, I agree to take part Participant information sheet Version No. 1 Date: 19/11/22